drugset / Trial / NCT04979611

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

NCT04979611 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

The small insulinoma can not be detected by the CT or MRI. We use 68Ga-NOTA-exendin-4 positron emission tomography/computed tomography (PET/CT) to detect the insulinoma for the patient diagnosed with endogenous hyperinsulinemic hypoglycaemia. And the diagnostic value will be performed. A single dose of 37-111 Mega-Becquerel (MBq) 68Ga-NOTA-exendin-4 will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

Timeline

Start
2020-08-01
Primary completion
2025-08-01
Completion
2025-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NOTA-exendin-4 Diagnostic / imaging agent 37 mbq Intravenous
Subject 68Ga-NOTA-exendin-4 Diagnostic / imaging agent 111 mbq Intravenous

Indications